The American Journal of Managed Care1d
NCCN Publishes Patient Guidance on Genetic Testing for Cancer Risk
A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—published a new resource to ...
News Medical on MSN1d
National Comprehensive Cancer Network: New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic ...
The American Journal of Managed Care5d
Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...
Cancer Therapy Advisor3d
SABCS 2024: Research Roundup
Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.
Le Lézard1d
Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials
Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for ...
News Medical on MSN7d
National Comprehensive Cancer Network: NCCN Joins International Meeting to Improve Cancer Care in the Middle East and North Africa Region
Two-day symposium in Riyadh, Saudi Arabia brings together leading oncology professionals from across the MENA region to review updated treatment recommendations. RIYADH, Saudi Arabia, Jan.
Hosted on MSN7d
MYGN Stock Gains Following Collaboration With Hannah Storm
Myriad Genetics, Inc. MYGN recently announced an agreement with Hannah Storm, a nationally renowned sports broadcaster who ...
What to know about genetic testing for cancer, and when to request it
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Morningstar25d
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
The NCCN Guidelines Category of Preference is ... of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed ...